Smithfield Trust’s Zimmer Biomet ZBH Stock Holding History

Smithfield Trust’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32K	Hold	358	–	–	﹤0.01%	670
2025 Q4	$32K	Hold	358	–	–	﹤0.01%	671
2025 Q3	$36K	Hold	358	–	–	﹤0.01%	631
2025 Q2	$32K	Sell	358 -40	-10%	-$3.87K	﹤0.01%	637
2025 Q1	$45K	Sell	398 -48	-11%	-$5.13K	﹤0.01%	577
2024 Q4	$47K	Hold	446	–	–	﹤0.01%	582
2024 Q3	$48K	Hold	446	–	–	﹤0.01%	566
2024 Q2	$48K	Sell	446 -140	-24%	-$16.5K	﹤0.01%	552
2024 Q1	$77K	Hold	586	–	–	﹤0.01%	493
2023 Q4	$71K	Hold	586	–	–	﹤0.01%	492
2023 Q3	$65K	Hold	586	–	–	﹤0.01%	487
2023 Q2	$86K	Hold	586	–	–	0.01%	457
2023 Q1	$75K	Hold	586	–	–	﹤0.01%	467
2022 Q4	$75K	Hold	586	–	–	0.01%	452
2022 Q3	$61K	Hold	586	–	–	﹤0.01%	475
2022 Q2	$62K	Sell	586 -26	-4%	-$3.08K	﹤0.01%	502
2022 Q1	$79K	Sell	612 -18	-3%	-$2.17K	0.01%	480
2021 Q4	$79K	Sell	630 -40	-6%	-$5.24K	﹤0.01%	494
2021 Q3	$96K	Hold	670	–	–	0.01%	448
2021 Q2	$105K	Hold	670	–	–	0.01%	431
2021 Q1	$104K	Hold	670	–	–	0.01%	432
2020 Q4	$100K	Buy	670 +29	+5%	+$4.1K	0.01%	426
2020 Q3	$85K	Sell	641 -8	-1%	-$1.04K	0.01%	427
2020 Q2	$75K	Buy	649 +221	+52%	+$25.5K	0.01%	433
2020 Q1	$42K	Buy	428 +41	+11%	+$5.37K	﹤0.01%	477
2019 Q4	$57K	Sell	387 -15	-4%	-$2.07K	0.01%	503
2019 Q3	$53K	Sell	402 -74	-16%	-$9.56K	0.01%	520
2019 Q2	$55K	Hold	476	–	–	0.01%	511
2019 Q1	$59K	Buy	476 +15	+3%	+$1.71K	0.01%	475
2018 Q4	$47K	Hold	461	–	–	0.01%	486
2018 Q3	$59K	Buy	461 +18	+4%	+$2.14K	0.01%	502
2018 Q2	$48K	Sell	443 -54	-11%	-$5.88K	0.01%	537
2018 Q1	$53K	Sell	497 -6	-1%	-$697	0.01%	502
2017 Q4	$59K	Sell	503 -135	-21%	-$15.3K	0.01%	508
2017 Q3	$72K	Sell	638 -2	-0.3%	-$231	0.01%	458
2017 Q2	$80K	Sell	640 -184	-22%	-$21.8K	0.01%	448
2017 Q1	$98K	Buy	824 +455	+123%	+$51.6K	0.02%	409
2016 Q4	$37K	Sell	369 -165	-31%	-$17.7K	0.01%	558
2016 Q3	$67K	Sell	534 -2,002	-79%	-$247K	0.01%	464
2016 Q2	$296K	Hold	2,536	–	–	0.06%	199
2016 Q1	$263K	Hold	2,536	–	–	0.05%	215
2015 Q4	$253K	Hold	2,536	–	–	0.05%	218
2015 Q3	$231K	Hold	2,536	–	–	0.05%	237
2015 Q2	$269K	Hold	2,536	–	–	0.05%	222
2015 Q1	$289K	Hold	2,536	–	–	0.06%	242
2014 Q4	$279K	Hold	2,536	–	–	0.06%	240
2014 Q3	$248K	Hold	2,536	–	–	0.05%	265
2014 Q2	$256K	Hold	2,536	–	–	0.05%	265
2014 Q1	$233K	Hold	2,536	–	–	0.05%	302
2013 Q4	$229K	Hold	2,536	–	–	0.05%	299
2013 Q3	$202K	Hold	2,536	–	–	0.05%	315
2013 Q2	$185K	Buy	+2,536	New	+$190K	0.04%	317

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Smithfield Trust's ZBH Position: Q1 2026 in Review

Smithfield Trust held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 358 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #670.

Smithfield Trust first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $296K in Q2 2016. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Smithfield Trust held 358 shares of Zimmer Biomet worth $32K as of Q1 2026.
Smithfield Trust left its Zimmer Biomet share count unchanged in Q1 2026.
Zimmer Biomet made up ﹤0.01% of Smithfield Trust's portfolio in Q1 2026, its #670 holding.
Smithfield Trust first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
Smithfield Trust's Zimmer Biomet position peaked at $296K in Q2 2016.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.